02/12/2025
3:27 PM | Nokes Rachael (Reporting)
scPharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
9:56 AM | KING LUTHER CAPITAL MANAGEMENT CORP (Filed by)
scPharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
7:01 AM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:30 PM | scPharmaceuticals (Issuer)
Tucker John H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
5:04 AM | scPharmaceuticals (Filer)
| Form 10-Q/A | |
12/11/2024
5:30 AM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:48 PM | Lundbeckfond Invest A/S (Filed by)
scPharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
4:16 PM | scPharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/28/2024
3:30 PM | Nokes Rachael (Reporting)
scPharmaceuticals (Issuer)
| Form 4/A | |
08/28/2024
3:30 PM | SCHAEFFER LEONARD D (Reporting)
scPharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:51 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VI LLC (Reporting)
OrbiMed Genesis GP LLC (Reporting)
scPharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SCPH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for scPharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
08/15/2024
3:47 PM | ORBIMED ADVISORS LLC (Filed by)
scPharmaceuticals (Subject)
| Form SC 13D/A | |
08/13/2024
7:58 AM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
7:03 AM | scPharmaceuticals (Filer)
| Form 424B5 | |
08/12/2024
5:48 AM | scPharmaceuticals (Filer)
| Form 424B5 | |
08/12/2024
5:08 AM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:20 PM | scPharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2024
3:07 PM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
1:34 PM | LYTTON LAURENCE W (Filed by)
scPharmaceuticals (Subject)
| Form SC 13G | |
04/26/2024
3:26 PM | scPharmaceuticals (Filer)
| Form DEFA14A | |
04/26/2024
3:16 PM | scPharmaceuticals (Filer)
| Form DEF 14A | |
04/12/2024
3:14 PM | scPharmaceuticals (Filer)
| Form PRE 14A | |
04/05/2024
11:21 AM | BlackRock Inc. (Filed by)
scPharmaceuticals (Subject)
| Form SC 13G/A | |
04/02/2024
3:15 PM | scPharmaceuticals (Issuer)
Tucker John H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2024
11:15 PM | scPharmaceuticals (Filer)
| Form EFFECT | |
03/13/2024
3:49 PM | scPharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/13/2024
3:58 PM | scPharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/13/2024
3:08 PM | scPharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
